Skip to main content
Alfred Garfall, MD, Oncology, Philadelphia, PA, Hospital of the University of Pennsylvania

AlfredGarfallMD

Oncology • Philadelphia, PA

Hematologic Oncology

Assistant Professor, Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania

Join to view full profile

Dr. Garfall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Garfall's full profile

Already have an account?

  • Office

    Perelman Center for Advanced Medicine, 2nd Floor, West Pavilion
    3400 Spruce Street
    Philadelphia, PA 19104
  • Is this information wrong?

Summary

  • Dr. Alfred Garfall is an oncologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania. He received his medical degree from NYU School of Medicine and has been in practice 9 years. He specializes in hematologic oncology and is experienced in amyloidosis and multiple myeloma.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
  • New York University School of Medicine
    New York University School of MedicineClass of 2008

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2022 - 2025
  • PA State Medical License
    PA State Medical License 2011 - 2024
  • MA State Medical License
    MA State Medical License 2010 - 2011
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Identification and Validation of Predictive Biomarkers to CD19- and BCMA-Specific CAR T-Cell Responses in CAR T-Cell Precursors
    Alfred L Garfall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Predictors of T Cell Expansion and Clinical Responses Following B-Cell Maturation Antigen-Specific Chimeric Antigen Receptor T Cell Therapy (CART-BCMA) for Relapsed/Re... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • PD-1 Inhibitor Combinations As Salvage Therapy for Relapsed/Refractory Multiple Myeloma (MM) Patients Progressing after Bcma-Directed CAR T Cells 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Penn Medicine Awarded $14 Million NIH Grant to Apply CAR T Immunotherapies to Match More Patients in Need of Kidney Transplants
    Penn Medicine Awarded $14 Million NIH Grant to Apply CAR T Immunotherapies to Match More Patients in Need of Kidney TransplantsDecember 27th, 2021
  • Colin Powell’s COVID-19 Death Followed Cancer Diagnosis, Treatment
    Colin Powell’s COVID-19 Death Followed Cancer Diagnosis, TreatmentOctober 21st, 2021
  • Crossing the Finish Line
    Crossing the Finish LineDecember 3rd, 2019
  • Join now to see all

Hospital Affiliations

Dr. Alfred Garfall, Dr. Alfred Garfall, MD, Dr. A Garfall